Free Trial

Celularity (CELU) SEC Filings & 10K Form

Celularity logo
$2.94 +0.02 (+0.68%)
(As of 11/20/2024 ET)

Recent Celularity SEC Filings

DateFilerForm TypeView
11/15/2024
4:15 PM
Celularity (Filer)
Celularity Inc (Filer)
Form NT 10-Q
11/07/2024
7:10 AM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:30 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
6:24 AM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
4:25 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2024
4:20 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:15 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
4:23 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
4:24 PM
BERMAN RICHARD J (Reporting)
Celularity (Issuer)
Celularity Inc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2024
4:26 PM
BERMAN RICHARD J (Reporting)
Celularity (Issuer)
Celularity Inc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:15 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:26 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/24/2024
4:15 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
8:25 AM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
5:05 AM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
7:56 PM
Brigido Stephen (Reporting)
Celularity (Issuer)
Celularity Inc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:56 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Hariri Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:56 PM
Beers David C (Reporting)
Celularity (Issuer)
Celularity Inc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:56 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Haines John R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:56 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Fletcher Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:30 PM
Celularity (Filer)
Celularity Inc (Filer)
Form NT 10-K
03/19/2024
8:20 AM
Celularity (Issuer)
Celularity Inc (Issuer)
Fletcher Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:32 PM
Celularity (Subject)
Celularity Inc (Subject)
Dragasac Ltd (Filed by)
Form SC 13D/A
03/15/2024
4:36 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Genting Berhad (Reporting)
Lim Kok Thay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:01 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
4:15 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
8:05 AM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
8:46 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Hariri Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:38 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Kilcoyne Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:18 PM
Beers David C (Reporting)
Celularity (Issuer)
Celularity Inc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:22 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Haines John R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:10 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Fletcher Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:14 PM
Brigido Stephen (Reporting)
Celularity (Issuer)
Celularity Inc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
5:00 AM
Celularity (Subject)
Celularity Inc (Subject)
UNITED THERAPEUTICS Corp (Filed by)
Form SC 13G/A
02/02/2024
5:01 AM
Celularity (Filer)
Celularity Inc (Filer)
Form DEF 14A
01/23/2024
5:02 AM
Celularity (Filer)
Celularity Inc (Filer)
Form PRE 14A
01/17/2024
4:15 PM
Celularity (Subject)
Celularity Inc (Subject)
Dragasac Ltd (Filed by)
Form SC 13D/A
01/17/2024
4:22 PM
Celularity (Issuer)
Celularity Inc (Issuer)
Dragasac Ltd (Reporting)
Genting Berhad (Reporting)
Lim Kok Thay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:14 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
3:49 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
8:12 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
12/29/2023
3:47 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
12:46 PM
Celularity (Filer)
Celularity Inc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CELU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners